“…Unlike MEC, however, the squamous cell and adenocarcinoma portions of ASC are distinct and separate, without any evidence of mixing. Furthermore, ASC of the head and neck is more aggressive, with a reported 5‐year survival rate between 13% and 25%, whereas MEC has a reported 5‐year survival rate of 92%, 63%, and 27% for low‐, intermediate‐, and high‐grade disease, respectively …”